April 9th 2024 – We welcome professor Christine Allen from the University of Toronto, a renowned figure in drug formulation and development, and a distinguished researcher, industry leader, and entrepreneur. A co-founder of NanoVista, recognized in its groundbreaking work in high-precision, image-guided cancer therapy, Christine has held key roles in various biotech and pharmaceutical companies. Recently her startup, Intrepid Labs, has just come out of stealth mode.
